4D BIO3 RM: on-demand blood program USU site #: RAD-89-10528

Active Cooperative Agreement Awarded Last action

Award ID
HU00012020011
Recipient
Awarding agency
Obligated
$58,134,087

Award facts

Completion date 97% complete
Originally
Place of performance
United States

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment 4D BIO3 RM: on-demand blood program $0
Amendment $9,475,869
Amendment 4D BIO3 RM: on-demand blood program. Additional funds provided to support the 4TH year of this project from june 10, 2024 through june 9, 2025. $9,471,976
Amendment 4D BIO3 RM: on-demand blood program. The modification changes the PI on the subaward with safi biotherapeutics, INC. From DR. JON mogford to MR. Doug mcconnell.… $0
Amendment 4 BIO3 RM: on-demand blood program. The modification extends the period of availability, "article a.4 accounting and appropriation data, for 12-months from 24… $0
Amendment 4D BIO3 RM: on-demand blood program. Additional funds was provided to support the project from january 25, 2023 to january 24, 2024. $13,520,765
Amendment 4D BIO3 RM: on-demand blood program. IT restriction was removed against all costs and work that may have information technology considerations. $0
Amendment $375,000
Amendment 4D BIO3 RM: on-demand blood program. Additional funds was provided to support year 2 of this project from july 1, 2021 to june 30, 2022. $10,916,373
Amendment 4D BIO3 RM: on-demand blood program. This modification approves the subaward's rebudgeting of $2,441,037 of which $1,94,037.00 within their budget and… $0
Amendment Rebudget of funds to provide the subaward with massachusetts general hospital (MGH) additional funding in the amount of $984,977.63 to purchase equipment. 4D… $0
Original award $14,374,104
Show all 12

Subawards

Subrecipient Amount Awarded
The General Hospital Corporation Blood on Demand: Program Management and Infrastructure, whole blood components, cell differentiation summary and comparison, bioreactor development, prototype… $1,051,341
Sciperio Inc. $2,400,007
SAFI Biotherapeutics Inc. The objective of On-Demand Blood (ODB) is to develop and implement ODB biomanufacturing technology to produce "fresh" on-demand cellular (e.g. red blood cells… $2,000,000
The General Hospital Corporation Task 1: Source cell study Task 2: Optimize growth factors. Task 3: Define transcription factor. Task 4: Define geneticfree recombinant transcription factors.… $921,876
Sciperio Inc. Blood on Demand: Program Management and Infrastructure, whole blood components, cell differentiation summary and comparison, bioreactor development, prototype… $2,200,004
SAFI Biotherapeutics Inc. Cell sourcing, bioprocessing optimization research, downstream expansion, scale-up piloting, evaluation of pre-clinical in vitro and in vivo studies, regulatory… $3,000,000

Quick answers

Who received award HU00012020011?

HU00012020011 was awarded to The Geneva Foundation by Uniformed Services University of the Health Sciences (Department of Defense) on January 8, 2020.

How much is award HU00012020011 worth?

$58,134,087 has been obligated on HU00012020011.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login